An adaptable implementation package targeting evidence-based indicators in primary care: A pragmatic cluster-randomised evaluation

PLoS medicine

Volumn 17, Issue 2, 2020, Pages e1003045-

  Willis, Thomas A ^a   Collinson, Michelle ^a   Glidewell, Liz ^b   Farrin, Amanda J ^a   Holland, Michael ^a   Meads, David ^a   Hulme, Claire ^c   Petty, Duncan ^d   Alderson, Sarah ^a   Hartley, Suzanne ^a   Vargas Palacios, Armando ^a   Carder, Paul ^e   Johnson, Stella ^e   Foy, Robbie ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF EXETER   (United Kingdom)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

^e NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ATRIAL FIBRILLATION; CLINICAL AUDIT; CLINICAL DECISION SUPPORT SYSTEM; CONSTRUCTIVE FEEDBACK; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DRUG INTERACTION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; YOUNG ADULT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; CLINICAL AUDIT; COST-BENEFIT ANALYSIS; DECISION SUPPORT SYSTEMS, CLINICAL; DIABETES MELLITUS; DRUG INTERACTIONS; EVIDENCE-BASED MEDICINE; FEMALE; FORMATIVE FEEDBACK; GLYCATED HEMOGLOBIN A; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; IMPLEMENTATION SCIENCE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PRIMARY HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; UNITED KINGDOM; YOUNG ADULT;

EID: 85081074006     PISSN: None     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1003045     Document Type: Article

References (0)